Manufacturer of next-generation laser technology selects clinivation WorldView as its most comprehensive, authoritative resource for building its medical product submissions and registrations worldwide.
Natick, MA, February 27, 2008 – clinivation, Inc. announced today that Spectranetics Corporation (NASDAQ: SPNC), has selected clinivation WorldView® Online Regulatory Intelligence web service.”We are very pleased that Spectranetics has selected clinivation WorldView as their source for worldwide regulatory intelligence and procedures,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions. “Easy, online access will allow for immediate, unlimited access to country reports, forms, and templates for >99% of the world markets,” he continued.
Clinivation WorldView is your most comprehensive, authoritative, and up-to-date resource for building all of your medical device submissions and registrations worldwide. Clinivation WorldView also interoperates with clinivation Global® enterprise software to make building and tracking medical device submissions and registrations easier than ever before.
About Spectranetics Corporation
Founded in 1984, Spectranetics manufactures and sells the only excimer laser approved in the United States, Europe and Japan for use in minimally invasive cardiovascular procedures. This technology treats complex cardiovascular conditions by photo-ablating multiple lesion types into tiny particles that are easily absorbed into the blood stream. The Company’s disposable catheters use high-energy “cool” ultraviolet light to vaporize arterial blockages in the legs and heart, as well as scar tissue encapsulating pacing and defibrillation leads.
For additional information, visit www.spectranetics.com.